Kwality Pharmaceuticals Ltd.
Snapshot View

421.70 +20.05 ▲5.0%

28 September 2022, 12:15:00 PM
Volume: 16,970

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kwalitypharma.com
Market Cap 434.24 Cr.
Enterprise Value(EV) 457.82 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 115.64 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 3.62 Trailing Twelve Months Ending 2022-03
Industry PE 30.69 Trailing Twelve Months Ending 2022-03
Book Value / Share 183.95 Trailing Twelve Months Ending 2022-03
Price to Book Value 2.28 Calculated using Price: 418.50
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.04 Cr. 10,376,198 Shares
FaceValue 10
Company Profile
The company ‘Kwality Pharmaceuticals Limited' was incorporated on May 04, 1983 vide Certificate of Incorporation issued by the Registrar of Companies, Punjab, H.P. and Chandigarh. It is engaged in the business of manufacturing of broad range of finished pharmaceutical formulations in a dosage form. It carries out its production through state-of-the-art manufacturing units situated at 6th Mile Stone, Village Nag Kalan, Majitha Road, Amritsar - 143006, Punjab, which is also its registered/administrative office and another manufacturing facility situated at 1-A Industrial Area, Raja ka bagh, Jassur, Himachal Pradesh. Both of its manufacturing facilities are well equipped and multiple products are manufactured at these facilities. Since incorporation, the company is ever progressing in Domestic and International market based on its commitment towards high quality and timely supplies. It provides specified and quality products for its customers while maintaining honesty, integrity and loyalty to its employees and customers.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.99%
1 Week
-8.32%
1 Month
+45.04%
3 Month
+39.52%
6 Month
-22.19%
1 Year
-44.46%
2 Year
+659.82%
5 Year
+826.81%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.26 4.43 6.54 14.41 16.51 23.13 20.10 28.21 99.66
Return on Capital Employed (%) 10.52 9.58 12.34 19.64 19.19 21.91 18.49 26.36 98.00
Return on Assets (%) 2.66 2.21 2.90 5.37 5.29 7.50 6.90 9.97 47.33

Balance Sheet View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 18 19 22 26 30 37 46 61 181
Non Curr. Liab. 2 1 3 4 5 8 20 28 31
Curr. Liab. 15 17 27 42 62 61 68 78 130
Minority Int. 0 0 0 -1 -1 -1 -1 -1 -1
Equity & Liab. 35 37 51 71 96 105 132 166 341
Non Curr. Assets 13 13 13 18 21 30 43 60 113
Curr. Assets 22 24 38 53 75 75 89 106 228
Misc. Exp. not W/O 0 0 0 0
Total Assets 35 37 51 71 96 105 132 166 341

Profit Loss View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Net Sales 60 52 74 98 137 166 139 262 456
Other Income 0 0 0 1 1 1 4 2 4
Total Income 60 53 75 100 138 167 143 264 460
Total Expenditure -56 -49 -69 -89 -126 -151 -125 -233 -284
PBIDT 4 4 5 10 12 16 18 30 175
Interest -1 -1 -1 -2 -2 -2 -3 -3 -3
Depreciation -1 -1 -2 -3 -3 -3 -4 -6 -11
Taxation -1 -1 -1 -2 -3 -3 -3 -6 -42
Exceptional Items
PAT 1 1 1 3 4 8 8 15 120
Minority Interest 0 0 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 1 1 2 3 5 8 8 15 120
Adjusted EPS 1 1 2 3 4 7 8 15 116

Cash Flow View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1 1 -3 4 -1 14 6 27 64
Cash Fr. Inv. -3 -1 -2 -7 -6 -12 -18 -23 -63
Cash Fr. Finan. 3 1 6 5 5 -2 12 1 6
Net Change -1 1 0 2 -1 0 0 4 7
Cash & Cash Eqvt 1 1 1 3 2 1 2 6 13

Shareholding Pattern View Details >>

9 Qtrs 2019-03 (%) 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 50.14 50.14 51.52 51.52 54.13 54.24 54.24 54.43 54.45
Public 49.86 49.86 48.48 48.48 45.87 45.76 45.76 45.57 45.55
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 20 Sep 2022
Announcement under Regulation 30 (LODR)-Credit Rating
Pursuant to Regulation 30 of Securities and Exchange of Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Obligations) we wish to inform you that Company has received credit ratings from ICRA Ltd (Credit Rating Agency).
Thu, 08 Sep 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 and 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copies of notice published in Newspapers regarding 39th Annual General Meeting Book Closure and E-voting in Financial Express (English) and Punjabi Jagran (Punjabi) on Thursday September 08 2022.
Wed, 07 Sep 2022
NOTICE OF 39TH ANNUAL GENERAL MEETING OF THE COMPANY
Please find attached herewith copy of notice of 39th AGM to be held on Friday 30th September 2022 at the Registered Office of the company situated at VILLAGE NAGKALAN MAJITHA ROAD AMRITSAR PUNJAB-143601.

Technical Scans View Details >>

Tue, 27 Sep 2022
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days
Making Lower Lows for 3 days Making Lower Lows for 3 days
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 215,220.35 922.35 +2.8%
Divi's Laboratories Ltd. 97,697.75 3,694.50 +0.4%
Cipla Ltd. 88,665.27 1,097.60 -0.1%
Dr. Reddy's Laboratories Ltd. 69,609.45 4,264.00 +2.0%
Apollo Hospitals Enterprise Ltd. 61,007.11 4,284.00 +1.0%
Torrent Pharmaceuticals Ltd. 51,942.91 1,490.90 -2.8%
Max Healthcare Institute Ltd. 40,110.70 409.30 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 55.33 922.35 +2.8%
Divi's Laboratories Ltd. Consolidated 2022-06 31.40 3,694.50 +0.4%
Cipla Ltd. Consolidated 2022-06 35.70 1,097.60 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.30 4,264.00 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.06 4,284.00 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.85 1,490.90 -2.8%
Max Healthcare Institute Ltd. Consolidated 2022-06 63.58 409.30 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.30 922.35 +2.8%
Divi's Laboratories Ltd. Consolidated 2022-06 7.84 3,694.50 +0.4%
Cipla Ltd. Consolidated 2022-06 4.13 1,097.60 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.44 4,264.00 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.27 4,284.00 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.13 1,490.90 -2.8%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.24 409.30 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 922.35 +2.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,694.50 +0.4%
Cipla Ltd. Consolidated 2022-03 0.04 1,097.60 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,264.00 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,284.00 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,490.90 -2.8%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 409.30 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 922.35 +2.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,694.50 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,097.60 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,264.00 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,284.00 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,490.90 -2.8%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 409.30 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 922.35 +2.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,694.50 +0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,097.60 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,264.00 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,284.00 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,490.90 -2.8%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 409.30 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 922.35 +2.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,694.50 +0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,097.60 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,264.00 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,284.00 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,490.90 -2.8%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 409.30 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 922.35 +2.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,694.50 +0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,097.60 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,264.00 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,284.00 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,490.90 -2.8%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 409.30 -1.0%

FAQ's On Kwality Pharmaceuticals Ltd.

What is Kwality Pharma share price?

Can I buy Kwality Pharma shares now?

What is the Market Cap of Kwality Pharma?

What are the key metrics to analyse Kwality Pharma?

What is the 52 Week High and Low of Kwality Pharma?

What is the trend of Kwality Pharma share price?